Working to Make Your Child’s World

Every child undergoes a unique process of cognitive development. Some are quick learners, while some take more time to progress. However, children who are diagnosed with Autism Spectrum Disorder (ASD) often face a multitude of difficulties, which may impact their learning skills. IMPUTE is developing a digital therapy solution that will address your child’s learning needs.

Our goal is to provide you with the best digital therapeutic solutions to assist with the overall development of your child. We will specialize in the development of digital Rx as a more effective method to help children and parents cope with autism, ADHD and learning disabilities in general. Our therapeutic system is designed to assess children’s needs, and then provide them with the best possible treatment.

Digital therapeutics (DTx) 
and Autism Therapy

Impute is a pioneer in the field of digital therapeutics (DTx), focusing on the treatment of children who are affected by Autism Spectrum Disorder (ASD). Through our application, Autism Therapy, we will deliver evidence-based therapeutic intervention that is driven by a high quality, patented software program to treat a broad spectrum of learning challenges faced by children. Furthermore, our app will address the prohibitive cost of autism treatment and the severe shortage of trained therapists. Our objective is to deliver effective, convenient treatment at a fraction of the cost of traditional therapy.

We are implementing digital therapy through our AI based app, which will not require any intervention by human therapists.Our DTx treatment can be provided anywhere, anytime. The app will be accessible for support at all times, unlike human therapists. This is because our AI app involves a machine learning (ML) mechanism by which children can constantly learn and improve. It will provide personalized programs to fit the needs of each user and AI instruction will progress according to the user’s improvement. We will use deep data mining to collect progress-data for each child and display it in a way that is easily understood by parents. Our DTx app uses face tracking, eye tracking and body movements to acquire behavior-related information from each child and use it to reinforce learning

Applied Behavior Analysis

Applied behavioral analysis (ABA) is a type of therapy that can improve social, communication, and learning skills through positive reinforcement. It is considered to be the gold-standard treatment for children with autism spectrum disorder (ASD). Using the same foundation principles of ABA, we are developing a solution that can be adapted to your child’s specific needs.

Want to work with US ?

We at IMPUTE Inc. are looking for people who are passionate about redefining the healthcare delivery system with emerging technologies.

We are bringing together the latest technologies to create a new class of digital therapeutics. Through our applications, we aim to assist people who suffer from cognitive impairment. If you share the same passion, please join us!

join our team now

The Latest News

IMPUTE Inc. Announces Investment by i-nest capital to Accelerate Growth.

IMPUTE, Inc., a Tokyo based company, has announced a 150 million JPY (1.3 million USD) investment in its Series A funding by i-nest capital, a Tokyo-based venture capital firm.

IMPUTE was founded by Dr. Mayank Singh for the purpose of developing digital therapeutics for the autism spectrum disorder. The company is developing an application that uses AI technology and applied behavior analysis to treat and alleviate the symptoms of ASD. Applied Behavior Analysis (ABA) is an established intervention method to treat or alleviate ASD symptoms. IMPUTE will use the funds to expedite development of the app and for clinical trials..

i-nest capital was founded in 2019 and is headed by Mr. Takashi Yamanaka. Dr. Singh has expressed his gratitude to Mr. Yamanaka and the i-nest team for understanding IMPUTE’s vision and for their trust in the IMPUTE team. He has also expressed his gratitude to Mr. Toshihiko Honkura, a partner in i-nest capital, for making the investment process smooth and for his understanding of the niche area that digital therapeutics for ASD holds. Mr. Honkura will be appointed as external board member of IMPUTE Inc. Below is the link for the i-nest capital press release regarding the investment.

Below is the link for the i-nest capital press release regarding the investment.


IMPUTE has started clinical research on Autism therapy app for autism spectrum disorders at the National Center for Child Health and Development, Japan. Children aged between 18 months to 6 years who have been diagnosed with autism spectrum disorder or who are suspected of having autism spectrum disorder and are consulted with a counseling agency are eligible. Click the links below to view the patient recruitment and detailed application form. Feel free to contact us with any questions or enrollment in the study –

Click here >> atcl/column/19/102700113/

Nikkei BP article about IMPUTE’s efforts and its goal for autism treatment.